29 -6 (68) 2024 - Mahmudov R.B., Akhmedova N.Sh. - THE ROLE OF GENETIC MUTATIONS IN THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE

THE ROLE OF GENETIC MUTATIONS IN THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE

Mahmudov R.B. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Akhmedova N.Sh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

In modern medicine, a number of scientific studies are being conducted on the importance of genetic predisposition in the development of chronic kidney disease (CKD). This article presents the results of a study conducted to determine the level of APOL1 gene polymorphism in the pathogenesis of nephropathies of various etiologies in the Uzbek population. The analysis showed that APOL1 gene polymorphism G1 and G2 mutations were detected among the patients included in the study.

Key words: scientific, polymorphism, pathogenesis, nephropathies, genetic mutations.

First page

157

Last page

162

For citation:Mahmudov R.B., Akhmedova N.Sh. - THE ROLE OF GENETIC MUTATIONS IN THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE//New Day in Medicine 6(68)2024 157-162 https://newdayworldmedicine.com/en/article/3758

List of References

1. Assady S, Wanner N, Skorecki KL & Huber TB Glomerulyar salomatlik va kasalliklarda podotsitlar biologiyasiga oid yangi tushunchalar //J. Am. Soc. Nefrol 28, 2017;15(66):1707–1715.
2. Boger CA va Heid, IM (2011). Surunkali buyrak kasalligi: genom bo'yicha assotsiatsiyalarni o'rganishdan yangi tushunchalar. //Buyrak va qon bosimi tadqiqoti2011;34:225-234.
3. Cooper, A., Ilboudo, H., Alibou, VP, Ravel, S., Enyaru, J., Weir, W., Noyes, H., Capewell, P., Camara M., Milet, J., Jamonneau , V., Camara O., Matovu E., Bucheton B. va MacLeod A. (2017). APOL1 buyrak xavfi variantlari afrikalik tripanosomiaz bilan qarama-qarshi qarshilik va sezuvchanlik assotsiatsiyasiga ega. 2017; eLife 245-256
4. Fan L., Gao V., Nguyen BV, Jefferson JR, Liu Y., Fan F. va Roman RJ (2020). Buyrak gemodinamikasining buzilishi va glomerulyar giperfiltratsiya gipertenziya tufayli buyrak shikastlanishiga yordam beradi. //Amerika fiziologiya-buyrak fiziologiyasi jurnali, 2020; 319: F624-F635.
5. Freedman BI, Cohen AH. Gipertenziya bilan bog'liq nefropatiya: bu nomda nima bor? //Nat. Rev. Nephrol 12, 2016;27-36.
6. Kopp JB, Anders HJ, Susztak K, Podestà MA, Remuzzi G, Hildebrandt F, Romagnani P. Podocytopathies. Nat Rev Dis Primerlari. 2020 yil 13 avgust; 6(1):68. doi: 10.1038/s41572-020-0196-7. (15)
7. Kriz W. Lemley KV. Glomerulyar filtratsiya to'sig'iga mexanik qiyinchiliklar: moslashishlar va sklerozga yo'l. //Pediatr. Nephrol 32, 2017;405-417.
8. Limou Sofi va boshqalar. "APOL1 buyrak xavfi allellari: populyatsiya genetikasi va kasalliklar assotsiatsiyasi." //Surunkali buyrak kasalligidagi yutuqlar jild. 21.5 (2014): 426-33.
9. Madhavan SM, O'Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR. Oddiy buyrak va diabetik bo'lmagan buyrak kasalliklarida APOL1 lokalizatsiyasi. // J Am Soc Nephrol. 2011 yil noyabr;22(11):2119-28.
10. Nishizono R va boshqalar. FSGS o'sish bilan bog'liq podotsitlar stressiga moslashuvchan javob sifatida. // J. Am. Soc. Nefrol 28, 2931–2945 (2017). 15-51
11. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Xu CA. Apolipoprotein L1, yangi Bcl-2 gomologik domeni 3-faqat lipidlarni bog'laydigan oqsil, autofagik hujayra o'limini keltirib chiqaradi. // J Biol Chem. 2008 yil 1-avgust;283(31):21540-9.
12. Yusuf AA, Govender MA, Brandenburg JT, Winkler CA. Buyrak kasalligi va APOL1 // Hum Mol Genet. 2021 yil 26-30 aprel. rr129-137.
13. Ahmadova N.Sh ., Sulaumonova G.T., Muxammedjanova M.X., G‘iyosova N.O. Surunkali buyrak kasalligi uchun xavf omillarining paydo bo'lish chastotasi va tarqalishi bo'yicha o'tkazilgan tadqiqot natijalarining tahlili // Xalqaro joriy tadqiqotlar va sharhlar jurnali. 13-jild. 02-yanvar 2021 yil. R. 127-131.

    file

    download